Posted on the University of Oxford Department of Chemistry website.

New Update (Dec 2005) – Pancreatic Cancer project results presented at AACR-NCI-EORTC Molecular Targets Meeting Nov 2005

“quote – Using Screensaver Lifesaver / LigandFit technology, we have identified three promising leads Mol597, Mol238 and Mol628 for urokinase inhibition. Based on the docking studies these molecules show high potential as uPA inhibitors. These molecules can be used as lead molecules for the design of better uPA inhibitors as potential anti-cancer therapeutic agents. We are synthesizing these molecules and testing them for biological activity. “

To all my fabulous friends on this incredible international team, keep those mosheens crunching. Together, one molecule at at time, we are making a difference in the fight against this terrible disease. I’ve said it before and I’ll say it again, I could not be more proud than to say I work with such a caring and compassionate group of cancer fighters. Have a great Friday my friends.